More contraceptive counseling needed when prescribing class D/X drugs

Article

About one in six women of reproductive age has a prescription filled at some point for a class D or X (potentially teratogenic) medication, but only about half of them receives contraceptive counseling. . .

About one in six women of reproductive age has a prescription filled at some point for a class D or X (potentially teratogenic) medication, but only about half of them receives contraceptive counseling, fewer than half are filled by women using a prescription contraceptive or who are sterilized, and these women are only slightly less likely than those filling a prescription for a class A or B drug to have a documented pregnancy in the following 3 months (1.0% vs. 1.4% of prescriptions, respectively).

The findings come from a large retrospective cohort study involving almost 500,000 female members of a large health maintenance organization in Northern California.

The authors of the study say the findings underscore the importance of contraceptive counseling, which other studies have found affects the use of contraception and the rate of unintended pregnancy. They hope the findings are also noted by policymakers in a position to influence whether contraception is covered by health insurance plans, since the cost of contraception often plays a role in whether or not it is obtained and used.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Neal Barnard, MD, FACC, highlights AMA's new breast cancer prevention guidelines | Image Credit: pcrm.org.
Zachary Wagner, PhD, discusses the harms of bias in reproductive care | Image Credit: ornsife.usc.edu.
Ciera Kirkpatrick, PhD, shows how TikTok is transforming cervical cancer awareness | Image Credit: linkedin.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.